Home  Clinical trials Plendil™ (felodipine)
|
|
| Plendil™ (felodipine) Clinical Trial report summaries |
Plendil™ (felodipine) is a vasoselective calcium antagonist for hypertension and angina pectoris.
Please consult the prescribing information for the country concerned for guidance on the approved use of Plendil™ (felodipine). | Study Number | Completed Clinical Trial Report Summaries | D4385L00001 | A randomized, open-label study to evaluate the effects on blood pressure control, pulse wave velocity, as well as safety and tolerability of felodipine sustained release, alone and in combination with metoprolol, lisinopril or hydrochlorothiazide, in Chinese patients with mild to moderate essential hypertension. | SH-FEH-0024 (216 OL) | Dose Ranging, Safety and Tolerability Study of Felodipine ER in Pediatric Patients; A Multicenter, Double- Blind, Placebo-Controlled, Randomized, Parallel Group Study with an Optional Open-Label Extension. This report presents the results from the open-label extension of this study. | SH-FEH-0024 (216 DB) | Dose Ranging, Safety and Tolerability Study of Felodipine ER in Pediatric Patients; A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel Group Study with an Optional Open-Label Extension This report presents the results from the double-blind treatment phase of the study. |
|
|
|
|